I am a surgical oncologist who specializes in gastrointestinal pre-cancerous conditions and cancers of the colon, appendix, rectum and anus. In my practice, I emphasize the importance of personalized patient care by providing treatment options appropriate for the individual and the disease.
My expertise is in minimally invasive approaches to tumors with advanced endoscopic, laparoscopic and robotic techniques. Advanced endoscopic procedures include: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection and Transanal Endoscopic Microsurgery (TEM). These are procedures involving outpatient or overnight hospital stay and used for earlier stage tumors. For more advanced tumors, my expertise in laparoscopic and robotic surgery offers patients smaller incisions, less pain and a faster recovery. When feasible, I use nerve sparing techniques to preserve urinary and sexual function, and can often spare the sphincters – avoiding the need of a permanent bag (colostomy).
Similar to cervical cancer, anal cancer can be screened for and often prevented. Working with nurses and nurse practitioners, we offer an anal cancer screening and prevention program to high-risk patients, and treat pre-cancerous conditions such as anal dysplasia. As part of the program, we perform anal pap smears for screening and treatment utilizing high-resolution anoscopy (HRA).
Preventing and treating cancer is a team effort. We emphasize this integrated approach and work closely with specialists in medical oncology and radiation oncology, as well as others including genetic counselors, social workers and mental/emotional and physical health services. Members of this team discuss individual patients at our weekly multidisciplinary conferences to make sure that we can provide the most comprehensive care possible.
My clinical research interests focus on improving the outcomes and quality of care in patients with cancer. I have published many papers on the subject and presented at national meetings including: The Society of Surgical Oncology, American College of Surgeons and American Society of Clinical Oncology Quality Symposium.
- Nurkin SJ, Kane JM 3rd. Margin status, local recurrence, and survival: correlation or causation?. Surgical oncology clinics of North America 2012; 212:255-267